Navigation Links
Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego
Date:4/25/2011

SAN DIEGO, April 25, 2011 /PRNewswire/ -- Millennium Laboratories, a leading provider of prescription drug monitoring services and education to physicians and staff treating chronic pain, announced today that the company's founder and CEO James Slattery has been named as a semifinalist for the Ernst & Young Entrepreneur Of The Year® 2011 Award for the San Diego region. Slattery was selected as a semifinalist from nearly 165 nominations by a panel of independent judges. The Ernst & Young awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Award winners will be announced on June 16, 2011.

(Photo: http://photos.prnewswire.com/prnh/20110425/LA88476)

James Slattery launched Millennium Laboratories in late 2006 after a successful career that encompassed broadcast communications and real estate development.  Under his direction as chief executive officer in less than five years the company has built a solid reputation as a leader in pain management services, setting industry standards in drug testing and reporting, clinical research and education.  A national network of physicians now uses Millennium Laboratories' services to increase patient safety and improve patient care for people experiencing chronic pain.

Millennium Laboratories is certified as a training facility for clinical toxicologist scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy. In 2010 the company established the Millennium Research Institute, a national, non-profit center that conducts and disseminates original research focused on improving the experiences of people suffering from pain and pain-related disorders.

Millennium CEO James Slattery noted, "I am honored to have been selected as a semifinalist for the prestigious Ernst & Young Entrepreneur Of The Year award program. As a values-based organization, Millennium Laboratories places the needs of our physician network and their patients first. This is the cornerstone of our success and our reputation. The Ernst & Young acknowledgement is a direct outgrowth of the hard work, integrity and commitment to excellence of everyone on the Millennium team in establishing the gold standard in prescription drug monitoring."

The Ernst & Young Entrepreneur Of The Year awards program celebrates its 25th anniversary this year. The program has expanded to recognize business leaders in over 140 cities and over 50 countries throughout the world.

Regional award winners are eligible for consideration for the Ernst & Young LLP Entrepreneur Of The Year national program. Award winners in several national categories, as well as the overall national Ernst & Young Entrepreneur Of The Year award winner, will be announced at the annual awards gala in Palm Springs, California on November 12, 2011. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation's most prestigious gathering of high-growth, market-leading companies, and is held from November 9-13, 2011.

About Millennium Laboratories

Located in San Diego's life sciences cluster, Millennium Laboratories, Inc. is a national, research-based medication monitoring company whose test offerings, technology, customer support, educational resources and experts are specifically focused on clinicians who treat chronic pain. The company is recognized as a leader in pain management services, setting industry standards in drug testing and reporting, clinical research and education. Millennium serves as an industry, government and payer educator and a compassionate advocate for pain sufferers throughout the United States. The company is accredited by The Joint Commission, receiving the Gold Seal of Approval™ for healthcare quality and safety.  

Among the numerous scientific and research achievements of the company's renowned laboratory team, Millennium Laboratories is certified as a training facility for clinical toxicologist scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy.

As part of the company's commitment to pain management research and education, Millennium Laboratories established the Millennium Research Institute (MRI), a non-profit, national research center that conducts and disseminates original research focused on improving the experiences of people suffering from pain and pain-related disorders. MRI maintains several national academic partnerships and supports collaborative research by accessing Millennium Laboratories' unique database representing the U.S. pain population.  For more information, visit the Millennium Laboratories website, www.becausepainmatters.com.

About Ernst & Young's Entrepreneur Of The Year® Awards Program

Ernst & Young's Entrepreneur Of The Year® is the world's most prestigious business award for entrepreneurs. The award makes a difference through the unique way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Ernst & Young Entrepreneur Of The Year® celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited located in the U.S.


'/>"/>
SOURCE Millennium Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
3. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
4. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
5. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
6. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
7. Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
8. Millennium Pharmacy Adds First Client in New England
9. Reprocessed Catheters: A Growing Force In the US Electrophysiology Diagnostic Catheter Market, According to Millennium Research Group
10. Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
11. Millennium Pharmacy Expands in New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 Report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2015 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/24/2017)... -- ITL Limited, ( ASX : ITD ), une société ... les excellents résultats semestriels clos le 31 décembre 2016 ... complète « Résultats et mise à jour sur la croissance ... Faits marquants ... en hausse de 104 %) Bénéfice par ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... ... which specializes in thought leadership , media relations, social media, content marketing ... that will be powered through Act-On, an intuitive marketing automation platform. , Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Justice jointly issued a letter to withdraw previous guidance issued by ... gender identity. The guidance issued in May 2016 by the Obama Administration came ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) ... Meeting. KLS is a longtime supporter of the event. , "We are pleased ... Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track ...
(Date:2/23/2017)... Mass. (PRWEB) , ... February 23, 2017 , ... ... as an approved content provider for the National Institute for Health and ... and social care-related organizations in the National Health Service (NHS) to search, order ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):